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Revealing the NIR-triggered chemotherapy
therapeutic window of magnetic and
thermoresponsive nanogels†
Catalina Biglione, ‡a,b,c Julian Bergueiro, ‡a,d Stefanie Wedepohl, a
Bastian Klemke, e Miriam C. Strumia *b,c and Marcelo Calderón *a,f,g
The combination of magnetic nanoparticles and thermoresponsive nanogels represents an appealing
strategy for the development of theranostic probes. These hybrid nanocarriers present several advantages
such as outstanding properties for guided therapy, magnetic resonance imaging, and triggered release of
encapsulated cargoes. Most magnetic thermoresponsive nanogels are built with strategies that comprise
a physical interaction of particles with the polymeric network or the covalent attachment of a single par-
ticle to the linear polymer. Herein, we report a facile synthetic approach for the synthesis of magnetic and
thermoresponsive nanogels that allows the controlled incorporation of multiple superparamagnetic in-
organic cores as covalent cross-linkers. An ultrasonication-assisted precipitation–polymerization afforded
nanogels with sizes in the nanometric range and similar magnetization and light transduction properties
compared to the discrete magnetic nanoparticles. The theranostic capability of these nanocarriers was
further investigated both in vitro and in vivo. In vivo experiments demonstrated the capacity of these
materials as nanocarriers for near-infrared (NIR) triggered chemotherapy and highlighted the relevance of
the correct concentration/dose in this antitumoral modality to achieve a superior therapeutic efficacy.
Introduction
Smart nanogels have become materials of remarkable impor-
tance in nanomedicine due to their attractive capabilities of
responding to different external stimuli.1–3 In particular,
because of their versatility, the use of thermoresponsive nano-
gels in different biomedical applications such as drug delivery,
theranostics, and tissue engineering have recently gained
interest.4–6 Considering the outstanding properties of nanogels
like superior biocompatibility, high loading capacity, passive
targeting, etc., nanogels have been the focus of continuous
research for developing superior drug delivery systems.7 In this
regard, there is an increasing interest in the incorporation of
triggers able to respond to external stimuli for clinical anti-
cancer applications.8–10 The incorporation of photo-transdu-
cers, which are able to convert near-infrared (NIR) radiation in
the so-called biological window (wavelengths between 700 and
1000 nm) into heat, within the nanogel structure is of high
interest for remote triggering.11,12 This non-invasive NIR radi-
ation can be used to remotely generate a controlled amount of
heat that can lead to the collapse of the nanogel’s thermo-
responsive polymer network, thus triggering the release of
encapsulated drugs. This remotely triggered delivery strategy
takes advantage of the deep penetration of NIR laser light into
tissues and reduces the undesired non-selective heating and
ablation of healthy tissues.13–16
Therefore, the choice of the photo-transducer building
block in the construction of a smart nanodevice is crucial to
the system’s efficiency and applicability. Organic dyes,17 con-
ducting polymers,18 and anisotropic gold nanoparticles19 have
been widely utilized for this purpose. In this regard, iron oxide
magnetic nanoparticles (MNPs) present several advantages
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that makes them perhaps the best choice as phototransducers:
(a) they are capable of transducing NIR light into heat,20,21 (b)
MNPs also generate heat when excited with an alternating
magnetic field,22–25 (c) their paramagnetic properties make
them optimal candidates for magnetic resonance imaging
(MRI) contrast agents,26–29 and (d) magnet guided therapy can
be performed with these systems as well.30–33
Because of the above-mentioned reasons, many efforts have
been focused on the development of magnetic and thermo-
responsive nanogels (MNGs).34–36 A variety of approaches that
use non-covalent interactions have been considered for the
incorporation of MNPs into a nanogel’s polymeric matrix.
These range from a simple mixture of MNPs and nanogel
suspensions20,32,37 to the in situ synthesis of nanogels in the
presence of a solution of MNPs,35,38,39 or vice versa by the
in situ synthesis of MNPs in a nanogel dispersion.40,41
However, the non-covalent incorporation methods have impor-
tant drawbacks like the desorption of the MNPs or the aggrega-
tion of the particles inside the nanogels that affects both the
magnetic properties of the composites and the drug loading
capacity of the systems.
To overcome this disadvantage, MNPs can be incorporated
using covalent chemistry, thus allowing a more controlled and
stable union. The inherent aggregation of the MNPs, however,
makes the task of controlling the incorporation of the particles
in the polymer network challenging, as is reflected in the few
reports in the literature.42,43 The need for new approaches to
overcome the actual disadvantages of using magnetic hybrid
systems is therefore evident.
Hence, we decided to investigate a novel strategy with the
potential to bring the control over the discrete incorporation
of MNPs into a thermoresponsive nanogel network. We target
this new approximation to create a more advanced remotely
triggered drug delivery system. The construction of a nanogel
with dispersed magnetic particles on its polymer network will
allow: (a) fixing the magnetic cores in the interior of the
nanogel via a covalent bonding, avoiding particle aggregation
or loss; (b) maintaining the phototransducing properties of
discrete MNPs; (c) keeping magnetic properties close to the
ones of the MNPs; and (d) enhancing the hydrophobic drug
encapsulation capacity by maximizing the available MNP
hydrophobic surface.
In our synthetic approach, MNPs are used as cross-linkers in
the synthesis of oligoethylene glycol (OEG)-based nanogels. The
novel robust strategy for the synthesis of thermoresponsive mag-
netic nanogels (MNGs) described here is based on ultrasound-
assisted precipitation–polymerization. Furthermore, the obtained
MNGs were fully characterized and their in vitro and in vivo appli-
cations as potential theranostic agents were assessed.
Materials and methods
Materials
All chemicals were purchased from Merck and Acros Organics
and used as received. Doxorubicin hydrochloride was pur-
chased from Yick-Vic Chemicals & Pharmaceuticals. Water
used for the experiments was obtained from a Millipore water
purification system (18.2 MΩ cm).
Methods
Synthesis of magnetic nanoparticles. The synthesis of iron
oxide MNPs was carried out by the coprecipitation of iron
salts.44 Briefly, FeCl3·6H2O (16.136 g) and FeCl2·4H2O (5.556 g)
were placed in a 250 mL round bottom flask together with
130 mL of Milli-Q water. 70 mL of NH4OH (3 M) was added
dropwise and left under magnetic stirring for 15 minutes.
Then, the nanoparticles were magnetically separated, and the
supernatant discarded. The MNPs were resuspended in 20 mL
of HNO3 (2 M) and stirred for a further 15 minutes. To purify
the MNPs, they were washed with acetone (2x) and water (1x)
using magnetic separation.
Surface modification of the MNPs with the methacrylate
moieties (MNP@MEMO). To perform the surface functionali-
zation of the nanoparticles, we followed the protocol pre-
viously developed.31 Briefly, 50 mg of MNPs were suspended in
26 mL of an EtOH : H2O (1 : 1) mixture. Then 2 mL of 3-(meth-
acryloyloxy)propyl trimethoxysilane (MEMO) was added and the
resulting dispersion was sonicated 5 times for 2 minutes with
an ultrasonicator (70% power, Bandelin UW 2070 or Omni-
Ruptor 400 tip sonicator). The reaction mixture was purified
with magnetic separation and washed 3 times with acetone.
Finally, MNP@MEMO were resuspended in Milli-Q water.
Synthesis of magnetic thermoresponsive nanogels (MNGs).
Generally, diethylene glycol methacrylate (DEGMA, 0.8 mmol),
oligoethylene glycol methacrylate (OEGMA, 0.2 mmol) mono-
mers, HEMA (4 mol%), sodium dodecyl sulfate (SDS,
1.6 mol%) and ammonium persulfate (APS, 0.8 mol%) were
placed in a flask with 10 mL of distilled water. Then, 1.5 mg of
MNP@MEMO and N,N,N′,N′-tetramethylethylenediamine
(TEMED, 0.3 mL, 0.25 M) were added. The solution was heated
to 60 °C. The reaction mixture was ultrasonicated discontinu-
ously (6 times) at 70% of power for 15 minutes (70% power,
Omni-Ruptor 400 or Bandelin UW 2070 sonicator). The nano-
gels were purified by magnetic separation and subsequent
dialysis against water for 3 days at room temperature using a
50 kDa MWCO membrane. Different screening parameters
were studied such as the amount of MNP@MEMO,
DEGMA : OEGMA ratio, etc. (see Table 1).
Infrared spectroscopy (FT-IR). Transmittance and reflectance
IR studies were carried out using either a JASCO FT-IR 4100
spectrophotometer or an FT-IR NICOLET IN microscope in the
range of 4000–500 cm−1 with a resolution of 4 cm−1 and 32
scans.
Dynamic light scattering (DLS). DLS experiments were
carried out using a Malvern Zetasizer Nano-ZS 90 (Malvern
Instruments), equipped with a He–Ne laser (λ = 633 nm) and a
dispersion angle of 173°. Particle sizes and size distribution
were obtained from the average of 3 measurements of intensity
distribution curves.
Nanoparticle tracking analysis (NTA). NTA experiments were
performed on a Malvern NanoSight NS500 device equipped
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with a SCMOS camera and with a 635 nm laser under a dis-
persion angle of 100° to 25°. Video capture was performed
with a camera level, a sliding shutter and a slip gain set to 13,
800 and 350, respectively. For each sample 3 video frames were
recorded for 30 seconds with 25 FPS. Data analysis was per-
formed using NTA 3.0 0064 software.
Transmission electron microscopy (TEM). Transmission and
scanning electron microscopy samples were prepared by blot-
ting samples on carbon-coated copper grids (300 mesh,
QUANTIFOIL, Grosslöbichau, Germany) and visualized using
the TEM detector on a Hitachi scanning electron microscope
(SU8030, Hitachi, Tokyo, Japan) at 20–30 kV and 10 µA. A
0.03 mg mL−1 solution of each nanoparticle was employed in
the measurements.
Thermogravimetric analysis (TGA). Thermogravimetric ana-
lysis of the samples (1–10 mg) was performed on a Shimadzu
DTG-60 (Japan) analyzer. The measurement was performed at
temperatures ranging from 25 to 800 °C at a heating rate of
10 °C min−1 under N2 atmosphere.
NIR irradiation experiments. 200 µL of MNG solution were
placed in a PCR tube and irradiated with a 785 nm laser
(500 mW, 0.59 W cm−2) for 10 min to reach the plateau temp-
erature. The temperature was monitored with an FLIR E4
thermal camera (FLIR Systems GmbH, Frankfurt, Germany).
Each experiment was performed in triplicate and Milli-Q water
was used as blank. Different MNG concentrations were
evaluated.
Magnetization experiments. Magnetization measurements
were performed at the Quantum Materials CoreLab at the
Helmholtz-Zentrum Berlin using a Magnetic Property
Measurement System (5T-MPMS, Quantum Design) equipped
with a superconducting quantum interference device (SQUID)
magnetometer. The magnetization of the magnetic nanogels
(powder, 4 mg) was measured in the field range from −20 000
to 20 000 Oe and at different temperatures.
Magnetic resonance imaging (MRI). Prior to the measure-
ments, MNGs in different concentrations were fixed in 1%
agarose gel. T2-Weighted images and T2 relaxation times were
acquired using a Bruker 7T BioSpec (Bruker, Germany) with a
20 mm-Quadrature-Volume Resonator (Rapid Biomed). The T2-
weighted images were acquired using conventional spin echo
acquisition techniques (TR = 2000 ms) with TE values ranging
from 6 to 260 ms. The relaxivities, r2, were calculated from the
curve fit of the T2 measured relaxation rates (ΔR2 =
1/T2background − 1/T2, s−1) as a function of the iron concen-
tration (mM).
Deprotonation of Dox·HCl. For the deprotonation of doxo-
rubicin hydrochloride, 400 mg of Dox·HCl (0.690 mmol) were
dissolved in 400 mL Milli-Q H2O in a 1 L separatory funnel.
Then, 200 mL of dichloromethane (DCM) and 4 mL of tri-
methylamine (TEA) were added. The organic layer was separ-
ated, and the aqueous layer was washed again 6 times with
200 mL of fresh DCM. The combination of the organic layers
was dried with anhydrous sodium sulfate and filtered. The sol-
vents were removed under high vacuum to ensure the com-
plete disappearance of TEA.
Drug encapsulation. For the incorporation of doxorubicin,
1 mL of an aqueous solution of MNG (2 mg mL−1) was mixed
in 1 mL of Dox in THF at different concentrations (e.g. 1, 2, 3,
and 4 mg mL−1) and incubated for 16 h under mechanical agi-
tation at room temperature. Then, the MNGs were magneti-
cally separated from the solution and washed twice with water.
The remaining solution of each wash was quantified using UV-
vis spectrophotometry. The absorption was measured at
480 nm to calculate the efficiency of encapsulation and
loading of the drug. For this, a Dox·HCl calibration curve was
previously performed in THF to obtain the molar absorptivity
coefficient. Each experiment was performed in triplicate.
Drug release. To perform doxorubicin release assays, 10
samples of 100 µL of an MNG-DOX in solution (2 mg mL−1) at
different pH values (4.2, 5.0, 6, and 7.4) were prepared. All
samples began the release at the same time under mechanical
agitation, but each sample was separated at different times.
The system was separated by a magnetic field and the remain-
ing solution was quantified by UV-vis spectrophotometry.
Absorbance at 480 nm was measured to calculate the percen-
tage of release. These tests were performed at 37 and 50 °C.
Each experiment was performed in triplicate. For the release
studies triggered by NIR light, a similar protocol was followed,
but after 12 h, the samples were irradiated for 5 minutes with
a 785 nm laser (500 mW, 0.59 W cm−2). The UV spectra of the
supernatant were recorded before and after the irradiation.
Cell culture. HeLa cells (Leibniz Institute DSMZ – German
Collection of Microorganisms and Cell Cultures GmbH #ACC
57) were routinely cultured in RPMI 1640 medium (Gibco,
Thermo Fisher Scientific) containing 10% FBS (Biowest), 1%
Table 1 MNG reaction conditions and size (DLS) and thermoresponsivity characterization (turbidimetry)
Batch Molar ratio DEGMA : OEGMAa MNP@MEMO (mg) Diameter (nm) SD (nm) TCP (°C)
MNG1 0.8 : 0.2 0.6 650 225 46
MNG2 1.5 210 5 47
MNG3 2.3 277 11 47
MNG4 3.0 222 3 52
MNG5 1 : 0 1.5 185 46 30
MNG6 0.95 : 0.05 355 92 36
MNG7 0.9 : 0.1 286 19 40
MNG8 0.7 : 0.3 253 2 60
aHEMA (4 mol%), SDS (1.6 mol%), APS (0.8 mol%), TEMED (0.3 mL, 0.25 M) and water (10 mL).
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penicillin/streptomycin (Gibco, Thermo Fisher Scientific) and
1% non-essential amino acid solution (Gibco, Thermo Fisher
Scientific) at 37 °C and 5% CO2.
MTT test. 10 000 HeLa cells per well were seeded into 96
well plates and grown over night. The next day, the cells were
treated with fresh medium containing different 10-fold serial
dilutions of the MNGs and incubated for 48 h. The medium
was removed and the cells were washed twice with 200 µL per
well PBS. 10 µL per well MTT solution (5 mg mL−1 in PBS,
Sigma) in 100 µL per well fresh medium was added to the
wells and incubated for 4 h at 37 °C. The supernatant was dis-
carded afterwards, and formazan crystals were solubilized by
adding 100 µL per well isopropanol containing 0.04 M HCl.
Absorbance at 570 nm was read in an Infinite M200 Pro micro-
plate reader (Tecan). Relative viabilities were calculated by
dividing the absorbance values of wells containing treated
cells divided by the values of untreated cells (100%). The assay
was performed in duplicate and repeated 3 times
independently.
In vitro photothermal therapy. 10 000 HeLa cells were
seeded into 96 well plates and grown over night. The next day,
the cells were treated with different amounts of MNGs,
MNG-Dox or mixtures of both. For this, the MNGs were centri-
fuged, resuspended in a cell culture medium and added to the
wells. The plate was placed onto a magnet plate fitted to 96
well plates to concentrate the particles on the surface of the
cells. The plate was placed under an NIR lamp (Hydrosun®
750) and illuminated for 5 minutes. The plates were returned
to the incubator for 24 h. Afterwards, the cell viability was
determined by CellTiter-Glo® Luminescent Cell Viability Assay
(Promega), according to the instructions of the manufacturer.
Briefly, 100 µL of CellTiter-Glo® Reagent was added to each
well, mixed for 2 minutes, and the lysates were transferred to a
white 96-well plate. After 10 minutes of signal stabilization at
room temperature, the luminescence was read in an Infinite
M200 Pro microplate reader (Tecan), and relative viability
values were calculated using the signals of untreated cells as
reference.
Determination of the maximum tolerated dose (MTD). All
animal procedures were performed in accordance with
national and local guidelines and regulations for care and use
of laboratory animals as described in Tierversuchsantrag G
0030/15 and approved by Landesamt Berlin für Gesundheit on
20.09.2018 for EPO GmbH Berlin-Buch. During all studies, the
behavior of the mice was monitored regularly as an indicator
for the tolerability of the treatments and to ensure that the
animals did not feel pain or endure stress. Female NMRI nu/
nu mice were treated with single doses of 10, 20, 40, 70, and
100 mg kg−1 MNG by intravenous administration through the
tail vein and the toxicity and tolerability were monitored by
body weight changes and behavioural indications. The
maximum tolerated dose of 100 mg kg−1 was then injected
daily for five consecutive days. The mice were observed for
another 15 days. Afterwards, the mice were sacrificed and the
organs (the spleen, kidneys, liver, heart, and lungs) were col-
lected and prepared for histopathological examination. For
this, paraformaldehyde-fixed, paraffin-embedded organ blocks
were cut into sections and stained with hematoxylin and
eosin. In addition, the biodistribution was measured using
MRI as described above.
In vivo MNG accumulation in tumor. Female NMRI nu/nu
mice were injected with 1 × 107 A549 cells subcutaneously. The
mice were injected intravenously through the tail vein with a
single dose of 100 mg kg−1, once the xenograft tumors reached
about 100 mm3 (∼day 7 after inoculation). A single dose of
doxorubicin (8 mg kg−1) served as a control. Different groups
of mice (n = 3 mice per group) were sacrificed after 2 h, 6 h,
12 h, 24 h and 48 h and the tumors were collected for analysis.
In vivo photothermal tumor therapy. Female NMRI (nu/nu)
mice bearing A549 xenograft tumors were randomly distribu-
ted into different groups (n = 5 mice per group). When the
tumor size reached 80–100 mm3, a single dose of 100 mg kg−1
MNG or MNG-Dox was injected intravenously through the tail
vein. 12 h after injection, the tumors were irradiated for
5 minutes with an NIR laser (785 nm, 500 mW). To compare
the different application routes, the other groups of mice were
treated with injections of 46 µL of a 16 mg mL−1 MNG or
MNG-Dox dispersion directly into the tumor and the tumors
were irradiated 5 minutes after intratumoral injection for
5 minutes as for the other groups as mentioned before. Tumor
volume and body weight was monitored until day 38, after




To covalently introduce MNPs into the polymeric network of
nanogels, we propose a facile method inspired by our pre-
viously reported ultrasound-assisted precipitation–polymeriz-
ation.45 This strategy presents several advantages such as short
reaction times, no necessity for an inert atmosphere, and low
polydispersity of the formed nanogels. More importantly, the
use of ultrasonication guarantees the colloidal stability of the
MNPs during the synthesis, which ensures an even distri-
bution of the inorganic cores in the network. In our strategy,
the MNGs will be composed of two main building blocks:
(a) MNPs as cross-linking blocks. MNPs decorated with meth-
acrylate moieties on their surface were synthesized by the
functionalization of bare MNPs—spherical nanoparticles with
an average diameter of 10 ± 3 nm (Fig. S1 and 2†) constructed
with (trimethoxysilyl)propyl methacrylate (MEMO), as reported
earlier.44 This functionalization was performed by an improved
ultrasonication-based method previously reported by our
group and it afforded MEMO-coated MNPs (MNP@MEMO)
with similar size and dispersity as the bare ones.31
The functionalization was confirmed by the appearance of
the signal characteristic of silane at 1200 cm−1 in Fourier
transform infrared spectroscopy (FT-IR) (Fig. S1†) and scan-
ning and transmission electron microscopy (SEM and TEM)
(Fig. S2†).
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(b) Thermoresponsive polymeric network. Commercially avail-
able oligoethylene glycol methacrylate (OEGMA) can be polymer-
ized in a simple and versatile manner. Their principal advantage
is that the system’s cloud point temperature (TCP) can be regu-
lated with precision by changing the ratio between monomers
with long and short pendant chains.46 Apart from this, the
resulting polymers present attractive properties such as high col-
loidal stability in water, biocompatibility, thermosensitivity,
etc.47–50 Moreover, thermoresponsive nanogels can be syn-
thesized with control over their size that allowed their use in
passive targeting modalities for tumor accumulation, taking
advantage of the well-known enhanced permeability and reten-
tion effect (EPR).16,18,51 The combination of crosslinked OEG
polymers with non-covalently entrapped MNPs has been reported
with promising properties in theranostic devices for controlled
drug delivery and magnetic hyperthermia.52–59 Nevertheless, to
the best of our knowledge, no report regarding the properties of
these types of systems as phototransducers have been published
so far. Moreover, we incorporated a hydrophilic monomer,
2-hydroxyethyl methacrylate (HEMA), to minimize the impact on
the hydrophobic–hydrophilic balance of the resulting system.
To overcome all intrinsic problems of MNPs in the syn-
thesis methodologies, we have utilized a precipitation–
polymerization strategy that involves ultrasonication assist-
ance. The use of ultrasound has two reasons: (a) on the one
hand, as we had reported,45 it affects directly the seeding
process of precipitation–polymerization, giving a superior
control over the size of the formed nanogels and (b) on the
other hand, it guarantees a good dispersion of the magnetic
particles that tend to easily aggregate during the nanogel for-
mation process.
This new approach in the synthesis of MNGs allows us not
only to evenly distribute the MNPs in the polymer network but
also to achieve control over both the size and transition
temperature.
First, we analyzed the influence of the amount of inorganic
cross-linkers in the MNG synthesis on the size and cloud point
temperature (TCP) of the nanogels. We kept a molar ratio of
0.8 : 0.2 (DEGMA : OEGMA) constant and varied the amounts
of the MNPs from 0.6 to 3 mg (Table 1). The size of the MNGs
determined using dynamic light scattering (DLS) was around
200 nm for all MNP@MEMO amounts but for the lower
amount, 0.6 mg, larger sizes of 650 nm with a large standard
deviation (Fig. 1B and Table 1) were observed. Regarding the
thermoresponsiveness of the MNGs, we determined the TCP
with turbidimetry and found values around 46 °C for MNGs
with 0.6 to 2.3 mg of MNP@MEMO and a TCP of 52 °C for
MNGs with 3 mg. Thus, only the incorporation of amounts
higher than 2.3 mg of magnetic nanoparticles per batch had
an influence on the thermoresponsive behaviour of the nano-
gels. Hence, MNGs with 1.5 mg of MNP@MEMO showed a
better balance of incorporation of magnetic particles and less
aggregation and were therefore chosen for further studies. A
more in-depth study on the size of the selected MNGs was per-
formed. A size distribution analysis of TEM images revealed a
mean diameter of 99.2 nm and PDI of 0.24 (Fig. 1D, Fig. S3
and S4†). These smaller diameter values are expected since the
nanogels collapse in the dry conditions that electron
microscopy techniques require.
The influence of the molar ratio between DEGMA : OEGMA
on thermoresponsiveness was assessed by keeping the amount
of MNP@MEMO constant (1.5 mg). All resulting nanogels pre-
sented sizes between 200 and 300 nm without a clear trend
(Fig. 1C). The colloidal stability of the system decreased with
increasing the DEGMA feed ratio as reflected by the SD
(Table 1). Contrarily, the TCP values showed a clear tendency:
Fig. 1 (A) Synthesis of MNP@MEMO and MNG. Influence of (B) MNP@MEMO amounts, and (C) DEGMA molar ratio on the size and TCP of the result-
ing MNGs. (D) TEM and SEM micrographs of the MNGs. The scale bars denote nm.
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as the amount of the hydrophobic monomer (DEGMA)
increased, the TCP decreased, which is in concordance with the
literature.60 Therefore, we could fine-tune the TCP values into
the relevant range for biomedical applications.
Conditions of molar ratio 0.8 : 0.2 DEGMA : OEGMA with
1.5 mg of MNP@MEMO were chosen due to their size
(210 nm) (Fig. S5†), a TCP of 46 °C (Fig. S6†), and colloidal
stability, fulfilling the requirements of a NIR-triggered drug
delivery device. The successful incorporation of magnetic par-
ticles into the MNGs under these synthetic conditions was con-
firmed by FT-IR (Fig. S7†). The disappearance of the double
bond conjugated with the carbonyl group between 1685 and
1665 cm−1 indicated the successful polymerization. In
addition, the presence of the characteristic bands at
2925 cm−1 and 2869 cm−1 (C–H aliphatic stretching), at
1728 cm−1 (CvO stretching, esters) verified the polymer struc-
ture of the MNGs. Moreover, thermal gravimetric analysis
(TGA) revealed that, while the bare MNPs and MNP@MEMO
had only marginal weight loss, the MNGs suffered a significant
loss (56.2 wt%), which can be attributed to the polymer
network and the rest arising from the inorganic material
(43.8 wt%) (Fig. S8†).
The size and morphology of the system was studied under
diluted conditions with nanoparticle tracking analysis (NTA)
finding similar hydrodynamic sizes as with DLS (Fig. S9†).
Transmission and scanning electron microscopy (TEM/SEM)
images confirmed the morphology of the hybrid nanogels
(Fig. 1D) as having a globular shape and a high number of
MNPs distributed in polymeric material.
The dispersions of the MNGs had high colloidal stability
compared to other magnetic systems (greater than 6 months,
Fig. S5†) and the nanocarriers could be easily isolated with a
magnet (Fig. S10†). In case of any aggregation that could be
observed at high concentrations, the system can be easily
redispersed by mild sonication. To confirm their superpara-
magnetic properties, magnetization measurements were per-
formed in the presence of an external field at different temp-
eratures (27, 37, 45, and 50 °C). The superparamagnetic behav-
iour was demonstrated since no hysteresis cycles were
observed at any of the temperatures studied (Fig. 2A). A com-
parison of MNP@MEMO and MNGs (normalized to the in-
organic weight content, 43.8%) (Fig. S11†) revealed a negligible
loss of magnetization properties. This supports the fact that
the use of MNPs as covalent crosslinkers in the gel network
prevents their aggregation and their magnetic properties
almost remain intact. As the system contains a thermosensitive
polymer that may change the proximity between the magnetic
cores, we studied the effect of the temperature on the magnetic
behaviour (Fig. 2B). We observed that the magnetization
decreases linearly with the temperature as expected, and the
magnetization was not affected near the TCP of the system.
In order to demonstrate the potential of the nanogels as
MRI contrast agents, we characterized the relaxation times of
the nanogels using a magnetic resonance imaging (MRI)
scanner (Fig. 2C). The MNGs presented similar transversal
relaxation times (r2) comparable to commercially available con-
trast agents (187 mM−1 s−1), highlighting the potential of
these hybrid systems as theranostic probes.61
The capacity of MNPs to transduce heat from NIR light and
consequently their applications in photothermal therapy has
been reported.35,62,63 Hence, we tested the photothermal con-
version capability of the nanogels under irradiation with NIR
light. For this, we placed small volumes of the MNGs at
different concentrations in a PCR tube and irradiated from
above with a 785 nm laser (500 mW, 0.59 W cm2) continuously
for 10 min. The temperature was monitored with a thermal
camera during the whole experiment. A concentration-depen-
dent heat generation capacity was found of 5 °C for the most
dilute solution (0.063 mg mL−1) and a maximum of 22 °C for
the highest concentration (4 mg mL−1) reaching a temperature
of 46 °C (Fig. 2D). In addition, we analyzed the photothermal
capacity of MNP@MEMO. To compare both systems, we
studied the temperature increase at different concentrations of
the inorganic material. For this, we normalized the MNG data
to the iron oxide nanoparticle content (Fig. S12†). While com-
paring the values, it can be demonstrated that at the same
amount of phototransducer, MNP@MEMO, similar heating
curves were observed. Therefore, we could prove the capacity of
MNGs to act as phototransducers and that the nanogel
network does not interfere in the heating capacity of the mag-
netic nanoparticles.
Doxorubicin encapsulation and release studies
With the purpose of studying the capacities of these materials
as nanocarriers, we selected doxorubicin (Dox) as an anti-
cancer model drug. We studied the encapsulation efficiency
(EE) of the MNGs using different concentrations of Dox.
Encapsulation efficiencies close to 30% were reached at Dox
concentrations ranging from 1 to 4 mg mL−1. The drug
loading content (DLC) in the systems was between 15 and 40%
(Fig. 3B and C). These values are close to and even higher than
those that can be found in the literature for similar
systems.52,58 This fact could be attributed to the nature of the
Fig. 2 (A) Magnetization curve of the MNGs at 27 °C. (B) Magnetization
of the MNGs at 10 000 Oe with increasing temperature. (C) T2-Weighted
MRI images and MRI transverse relaxation times of the MNGs at different
concentrations. (D) Heating curves under 10 minutes of NIR laser
irradiation of the MNGs at different concentrations.
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hybrid system in which MNPs are not aggregated and which
allows a higher incorporation of the hydrophobic drug.
We evaluated the drug release under different conditions
such as pH, temperature, and NIR irradiation using nanogels
of 40% DLC (Fig. 3D). In acidic medium (pH 4.2 and 5), Dox-
loaded magnetic nanogels (MNG-Dox) showed an enhanced
release compared to higher pH values like 6 or 7.4. This
enhancement can be explained by considering the fact that
Dox can be protonated at acidic pH, gaining hydrophilicity
and thus being released from the hydrophobic domains of the
hybrid network. Moreover, we investigated the influence of the
thermoresponsive behaviour of the nanogels on Dox release.
As expected, a temperature above the TCP of the nanogels
(46 °C) resulted in an increased release from 25% to 60% at
pH 4.2. This perfectly fits our application rationale of enhan-
cing the release in an acidic tumor microenvironment.64 To
analyze the mechanism of drug release, the data obtained
were fitted with the most relevant kinetic models for drug
release: zero-order, first-order, Higuchi, Korsmeyer–Peppas
and Hixon–Crowell release models.65 For all the experiments,
the model with the highest R2 was considered as the best fit of
the release data. The analysis of the release kinetics revealed
that most probably the drug release follows the Korsmeyer–
Peppas model (Fig. 3D and Table S1†), which is expected since
this model is an equation to describe drug release from poly-
meric systems.66
To confirm that Dox release can be triggered by NIR-
induced temperature increase and subsequent collapse of the
network, we irradiated the MNG solution for 5 minutes with
an NIR laser (785 nm, 500 mW, 0.59 W cm2) at pH 5 and 6 and
measured the release after 12 hours. In both cases, we
observed that the release can be boosted by 35% (pH 6) and
60% (pH 5) by NIR irradiation (Fig. 3E). However, a second
NIR irradiation did not affect the release profile, indicating
that the maximum release was achieved with a single
irradiation of 5 min.
NIR-triggered chemotherapy evaluation in vitro
The ability of nanogels to perform as theranostic probes
clearly depends on factors such as their cytotoxicity, their
cancer cell killing capacity, etc. As a first assessment of bio-
compatibility, we studied the influence of the nanogels on cell
viability using tetrazolium dye (MTT) assay on HeLa cells
(Fig. S13†). After 48 hours of incubation of HeLa cells with the
MNGs, half maximal inhibitory concentrations (IC50s) of
around 0.1 mg mL−1 were obtained. These values reflect the
low toxicity of magnetic nanogels based on ethylene glycol and
silanized magnetite nanoparticles.52
MNG interaction with the cells was studied by means of
confocal visualization. After 12 hours of incubation of HeLa
cells with different amounts of SureBeads™, MNG, and
MNG-Dox, all magnetic systems can be observed in the sur-
roundings of the cell with no clear evidence of cell internaliz-
ation and an obvious cell death induced by the drug-loaded
system (Fig. S14†). To explore cell interaction, the cells were
trypsinized, washed, and settled in a magnetic rack. The
MNGs could be observed under the microscope after the
washing step (Fig. S15†). The non-interacting control
(SureBeads™) could not be observed under the same con-
ditions. This made us think that a non-specific interaction
between the MNGs and the cellular membrane was occurring.
We relied on this interaction to help in the tumor accumu-
lation of the MNGs and the subsequent triggered antitumoral
therapy.
Consequently, we studied the potential of the MNGs for
photothermally induced chemotherapy of cancer cells.
Different amounts of MNGs or MNG-Dox (40% DLC) were
added to HeLa cells in 96-well plates and concentrated on the
surface of the cells using a magnet. Then, the whole plate was
irradiated for 5 minutes with NIR light. However, an identically
treated second plate was not irradiated and it served as a
control. 24 h after treatment, a concentration-dependent
decrease in cell viability approaching complete cell death was
observed for the non-loaded MNGs (Fig. 4A) after irradiation.
With this, we demonstrate the ability of the MNPs in the
network as phototransducers that increase the local tempera-
Fig. 3 (A) Schematic representation of doxorubicin load and triggered
release from the MNGs. (B) Drug loading content and (C) encapsulation
efficiency at different Dox concentrations. (D) Release studies at
different pH values and temperatures. (E) NIR-triggered release studies
(time in log scale).
Fig. 4 Relative viabilities of HeLa cells 24 h after treatment with (A)
MNGs, (B) MNG-DOX, and (C) a mixture of MNG-DOX and MNGs, with
and without NIR irradiation for 5 minutes as calculated by ATP content.
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ture sufficiently to enhance the cell death, making them suit-
able for NIR-triggered chemotherapy.
To analyze the NIR-triggered chemotherapeutic effect of
both NIR irradiation and Dox activity, the cell viability of the
nanogels loaded with Dox was tested with and without
irradiation (Fig. 4B). Due to the high loading capacity of the
MNGs, the cells treated with MNG-Dox already had a highly
reduced viability of only about 20% without NIR irradiation,
merely due to the chemotherapeutic effect of Dox. To make
the NIR-triggered chemotherapeutic effect visible, we mixed
MNG-Dox with the non-loaded MNGs, thereby reducing the
drug concentration but keeping the amount of MNGs (the
agent that produces heat upon irradiation) similar and
repeated the irradiation experiment (Fig. 4C). Without
irradiation, this mixture reduced the cell viability to about
40%, due to the intrinsic inhibitory activity of Dox. After
irradiation, the cell viability decreased to 16% using 37.5 µg of
MNG-Dox and 15 µg of MNG and decreased to complete cell
death at higher concentrations (150 µg of MNG-Dox and 15 µg
MNG), clearly demonstrating the NIR-triggered chemothera-
peutic effect. It is worth mentioning that such promising
results were achieved by NIR irradiation for only 5 minutes,
whereas when employing an alternating magnetic field, a 2 h
exposure was needed as reported.58
NIR-triggered chemotherapy evaluation in vivo
Considering the promising results in vitro, we became interested
in investigating their potential for heat-mediated chemotherapy
in vivo. First, the maximum tolerated dose of the MNGs was
studied in healthy NMRI nude mice to evaluate sufficient doses
and short-term toxicity. Five doses with increasing amounts of
MNG (10, 20, 40, 70, and 100 mg kg−1) were injected intra-
venously through the tail vein and the mice were observed for
15 days. Since there were no signs of compound-related toxicity,
five extra injections of 100 mg kg−1 were performed for five con-
secutive days to reach a total accumulated dose of 500 mg kg−1.
One group of mice was sacrificed after the last treatment, and a
second group was kept for another 13 days without showing
signs of toxicity or body weight loss (Fig. 5A). In addition, the
general behaviour of mice was not altered, indicating a good tol-
erability to the treatments.
Selected organs were collected (the liver, lung, spleen,
kidneys, heart) and prepared for histopathological examin-
ation. The sections showed no specific toxicity-related altera-
tions (Fig. 6). Particle accumulation was visible in the sections
of the liver and spleen; however, apart from a slight dark stain-
ing of the liver, the mice did not show macroscopically
obvious discoloration of the other organs or skin. In agree-
ment with this, biodistribution measured by MRI showed the
accumulation of MNGs mainly in the liver and kidneys and
smaller amounts of the nanogels were detected in the spleen,
lungs, and heart (Fig. S16 and S17†). Regarding the degra-
dation and excretion of MNGs, we speculate that the degra-
dation of our system will be highly comparable to those of
other OEG-based nanogels since the thermoresponsive
polymer is the most enzyme reactive component.67 It is
expected that the magnetic nanoparticles will be excreted
based on related reports of magnetic nanoparticles.68 We
further studied the accumulation (which we expect via EPR) of
the magnetic nanocarriers in A549 xenograft tumors in nude
mice. Doses of 100 mg kg−1 were injected intravenously, and
Fig. 5 (A) Body weight change for mice treated with MNGs five times
with the maximum tolerable dose of 100 mg kg−1. (B) Accumulation of
MNGs in the tumor at different time points determined using MRI.
Fig. 6 Paraffin-embedded formalin fixed H&E stained sections of the
selected organs of healthy mice treated with 100 mg kg−1 of MNGs 1×
daily for 5 days. Left: after day 5 and right: after day 18. Scale bar =
50 µm.
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different groups of mice were sacrificed after 2, 6, 12, 24, and
48 h. The tumors were collected and fixed in 1% agarose gel
for the quantification of MNGs by magnetic resonance
imaging (Fig. 5B and S18†). A homogeneous distribution of
the MNGs over the tumor volume was observed and a higher
concentration could be observed in the more vascularized
areas (Fig. S18†). A maximum mean MNG concentration of
12.3 mg mL−1 was accumulated 12 h after injection and
reduced after that time point. Hence, we determined the
optimal time window for therapeutic NIR irradiation after
intravenous injection to be 12 h.
MNG and MNG-Dox were injected intravenously (i.v.) in
A549 xenograft tumor bearing mice at doses of 100 mg kg−1.
12 h after injection, the tumor was irradiated once for 5 min
(following our findings in the in vitro release studies) with a
785 nm laser (500 mW) from a distance of 5 cm. The mice
were monitored for a further 23 days and the tumor volume
was measured twice per week (Fig. 7A, individual curves are
depicted in Fig. S19†). Mice injected with PBS solution were
used as reference for untreated tumor growth. The MNGs
interfered with the expected growth of the tumor, showing a
less aggressive growth profile compared to PBS. Similar values
were obtained while irradiating the tumors 12 h after the MNG
injection (Fig. 7A). This observation reflected that the ablation
damage produced by MNG heating was in this case neglect-
able. We target this MNG concentration window to observe the
NIR-triggered enhanced chemotherapy without interferences
from tumor ablation. Dox-loaded MNG (MNG-Dox) was com-
pared to non-formulated Dox injection at known therapeutic
concentrations for this particular in vivo setting.69,70 As
expected, almost no tumor growth was observed for Dox until
day 24 after injection day. After this period, the relative tumor
volume abruptly peaked up to values comparable with the
non-treated tumors at day 3.
Dox-loaded nanogels acted in a slower and constant
manner on tumor growth when the release was likely only trig-
gered by the local pH value, showing less growth inhibition in
the first 24 days but continued until day 34, where values
lower than the ones reached by the non-loaded MNGs were
observed. This trend was enhanced when MNG-Dox was irra-
diated with NIR light showing the benefit of combined pH and
NIR triggered Dox release from the nanogels. To further under-
stand the mode of action and efficacy of our system, we admi-
nistered MNGs by a different route. Doses of 45 µL (16 mg
mL−1) of MNGs and MNG-Dox were injected intratumorously
(i.t.) and instantly irradiated for 5 min similar to the previous
experiments and the tumor volume was comparably screened
(Fig. 7B, individual curves are depicted in Fig. S20†). Like in
the i.v. administration, the MNGs showed a less aggressive
tumor growth trend than the PBS control. However, upon NIR
irradiation, the tumor volume curve reached higher values,
comparable with the PBS ones. We speculate that a higher
MNG concentration in the tumor site was able to produce
enough heat that led to an increased blood flow and perfusion
to the tumor, promoting the overall tumor growth.71
The effects of a higher MNG concentration were also
observed for the experiments using Dox-loaded nanogels. The
free Dox inhibition effects were overcome by MNG-Dox,
showing no increase of the tumor volume until day 28. NIR
application resulted in a lower inhibition in mid-term (days 21
to 31) possibly by the same effect discussed above for the non-
loaded nanogels. However, long-term inhibition at day 34
reached values slightly lower than treatment without
irradiation with the Dox-loaded system.
To assess one of the known side effects of chemotherapy,
body weight changes in all mice were monitored for both i.v.
and i.t. (Fig. S21A and B† respectively) treatments. All mice
treated with MNG and MNG-Dox, as well as the controls (PBS
with and without irradiation), did not show any reduction in
the body weight. Only the group treated with free doxorubicin
showed decreasing body weights due to the toxic effects of the
drug itself.
Hence, these nanocarriers present a chemotherapeutic
activity triggered by NIR light with only 5 minutes of exposure.
In addition, similar or better results were observed compared
to those for other dual-responsive systems such as tempera-
ture/redox-sensitive,72 pH/redox dual responsive73 nanogels, as
well as for magnetic polymeric nanocarriers modified with tar-
geting groups.74,75
Conclusions
In conclusion, we report a facile synthetic approach of thermo-
responsive nanogels where magnetic nanoparticles are
employed as covalent cross-linkers. This new covalent strategy
prevents the leakage of the MNPs from the polymer network. A
fine control of sizes and cloud point temperature was achieved
by changing the amount of MNP@MEMO and the
DEGMA : OEGMA ratio. MNGs retain the magnetization, relax-
ation, and phototransducing properties of their parent mag-
netic nanoparticles. Moreover, doxorubicin was encapsulated
into the MNGs, finding encapsulations similar or even higher
to similar reported systems. In addition, we proved that its
release could be controlled either by pH or by external trigger-
ing with NIR light.
We demonstrated the successful NIR-triggered chemo-
therapy between local hyperthermia created by light-to-heat
Fig. 7 Relative tumor volume at different times after (A) intravenous
and (B) intratumoral application of magnetic nanogels and treatment
with and without NIR irradiation. PBS and free Dox were always adminis-
tered intravenously.
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conversion of the MNGs by NIR irradiation and the antiproli-
ferative effect of doxorubicin in vitro. In vivo experiments were
performed through intravenous and intratumoral adminis-
tration. Intravenous administration revealed an NIR-triggered
chemotherapeutic effect that improves Dox efficiency in tumor
volume reduction, both in the mid term and in the long term.
Tumor volume trends from intratumoral administration
revealed a similar situation. However, we observed a tumor
growth enhancing effect of the heat produced by the magnetic
phototransducer. This comparative study reflects the impor-
tance of the correct dose and drug concentration in the admin-
istration of the NIR-triggered delivery system. Such factors are
key for unleashing all the therapeutic potencies of the antitu-
moral modalities. In addition to their NIR-triggered chemo-
therapy capacity, it is worth mentioning that these hybrid
nanogels can be used for photothermal therapy as well as for
MRI, demonstrating their capacity as theranostic devices. It is
important to highlight that this work paves the way for further
clinical studies regarding the mechanisms that take place
when injecting and irradiating these type of nanocarriers.
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